Quantitative Assessment of Iron Accumulation in the Deep Gray Matter of Multiple Sclerosis by Magnetic Field Correlation Imaging

BACKGROUND AND PURPOSE: Deposition of iron has been recognized recently as an important factor of pathophysiologic change including neurodegenerative processes in multiple sclerosis (MS). We propose that there is an excess accumulation of iron in the deep gray matter in patients with MS that can be measured with a newly developed quantitative MR technique—magnetic field correlation (MFC) imaging. MATERIALS AND METHODS: With a 3T MR system, we studied 17 patients with relapsing-remitting MS and 14 age-matched healthy control subjects. We acquired MFC imaging using an asymmetric single-shot echo-planar imaging sequence. Regions of interest were selected in both deep gray matter and white matter regions, and the mean MFC values were compared between patients and controls. We also correlated the MFC data with lesion load and neuropsychologic tests in the patients. RESULTS: MFC measured in the deep gray matter in patients with MS was significantly higher than that in the healthy controls (P ≤ .03), with an average increase of 24% in the globus pallidus, 39.5% in the putamen, and 30.6% in the thalamus. The increased iron deposition measured with MFC in the deep gray matter in the patients correlated positively with the total number of MS lesions (thalamus: r = 0.61, P = .01; globus pallidus: r = 0.52, P = .02). A moderate but significant correlation between the MFC value in the deep gray matter and the neuropsychologic tests was also found. CONCLUSION: Quantitative measurements of iron content with MFC demonstrate increased accumulation of iron in the deep gray matter in patients with MS, which may be associated with the disrupted iron outflow pathway by lesions. Such abnormal accumulation of iron may contribute to neuropsychologic impairment and have implications for neurodegenerative processes in MS.

[1]  L G Nyúl,et al.  Numerical tissue characterization in MS via standardization of the MR image intensity scale , 2000, Journal of magnetic resonance imaging : JMRI.

[2]  E. Morgan,et al.  The Metabolism of Neuronal Iron and Its Pathogenic Role in Neurological Disease: Review , 2004, Annals of the New York Academy of Sciences.

[3]  R. Ordidge,et al.  The measurement of R2, R2* and R2' in HIV-infected patients using the prime sequence as a measure of brain iron deposition. , 1997, Magnetic resonance imaging.

[4]  J. Bulte,et al.  Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using MION‐46L enhanced in vivo MRI: Early histopathological correlation , 1998, Journal of Neuroscience Research.

[5]  J. Connor,et al.  Iron and neurodegenerative disorders , 2001, Brain Research Bulletin.

[6]  W Craelius,et al.  Iron deposits surrounding multiple sclerosis plaques. , 1982, Archives of pathology & laboratory medicine.

[7]  T. S. St. Pierre,et al.  Bi-exponential proton transverse relaxation rate (R2) image analysis using RF field intensity-weighted spin density projection: potential for R2 measurement of iron-loaded liver. , 2003, Magnetic resonance imaging.

[8]  P. Matthews,et al.  Thalamic neurodegeneration in multiple sclerosis , 2002, Annals of neurology.

[9]  Joseph A. Helpern,et al.  Quantitative MRI assessment of Alzheimer’s disease , 2007, Journal of Molecular Neuroscience.

[10]  P. Doherty,et al.  Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent , 1984, The Journal of experimental medicine.

[11]  Massimo Filippi,et al.  Multiple sclerosis: a white matter disease with associated gray matter damage , 2001, Journal of the Neurological Sciences.

[12]  J. Beard,et al.  Iron-deficient mice fail to develop autoimmune encephalomyelitis. , 2003, The Journal of nutrition.

[13]  Jim Mintz,et al.  Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases , 2005, Alzheimer's & Dementia.

[14]  R. Herfkens,et al.  Magnetic resonance imaging in multiple sclerosis: Decreased signal in thalamus and putamen , 1987, Annals of neurology.

[15]  Glyn Johnson,et al.  Magnetic field correlation imaging , 2006, Magnetic resonance in medicine.

[16]  B. Drayer,et al.  Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? , 1987, AJR. American journal of roentgenology.

[17]  S. LeVine,et al.  The Role of Iron in the Pathogenesis of Experimental Allergic Encephalomyelitis and Multiple Sclerosis , 2004, Annals of the New York Academy of Sciences.

[18]  R. Bakshi,et al.  T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. , 2002, Archives of neurology.

[19]  Rohit Bakshi,et al.  Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. , 2005, Archives of neurology.

[20]  C. W. Tjoa,et al.  MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis , 2005, Journal of the Neurological Sciences.

[21]  Supun Samarasekera,et al.  Multiple sclerosis lesion quantification using fuzzy-connectedness principles , 1997, IEEE Transactions on Medical Imaging.

[22]  R. Bakshi,et al.  Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients , 2001, Journal of the Neurological Sciences.

[23]  S. Sorbi,et al.  Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. , 2001, Archives of neurology.

[24]  Dewey Odhner,et al.  3DVIEWNIX: an open, transportable, multidimensional, multimodality, multiparametric imaging software system , 1994, Medical Imaging.

[25]  Mark A. Smith,et al.  Mechanisms by which metals promote events connected to neurodegenerative diseases , 2001, Brain Research Bulletin.

[26]  W. Macklin,et al.  Iron‐enriched oligodendrocytes: A reexamination of their spatial distribution , 1990, Journal of neuroscience research.

[27]  Robert Zivadinov,et al.  Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS , 2006, NeuroImage.

[28]  Alireza Minagar,et al.  Gray Matter Involvement in Multiple Sclerosis: A New Window into Pathogenesis , 2003, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[29]  P. Jezzard,et al.  Thalamic neurodegeneration in relapsing-remitting multiple sclerosis , 2003, Neurology.

[30]  I. Moseley,et al.  Signal intensity on MRI of basal ganglia in multiple sclerosis. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[31]  H. Schipper,et al.  Proinflammatory cytokines promote glial heme oxygenase‐1 expression and mitochondrial iron deposition: implications for multiple sclerosis , 2001, Journal of neurochemistry.

[32]  S. LeVine,et al.  Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice , 1998, Journal of Neuroimmunology.

[33]  Christine D. Dijkstra,et al.  Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats , 1995, Journal of Neuroimmunology.

[34]  W. Bradley,et al.  Iron accumulation in the basal ganglia following severe ischemic-anoxic insults in children. , 1988, Radiology.

[35]  S. LeVine,et al.  Iron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitis. , 1998, Life sciences.

[36]  R I Grossman,et al.  Three-dimensional proton spectroscopy of deep gray matter nuclei in relapsing–remitting MS , 2004, Neurology.